Biotechnology ResearchNorth Carolina, United States11-50 Employees
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
| Idera Pharmaceuticals Email Formats | Percentage |
| FLast@iderapharma.com | 82% |
| FirstLast@iderapharma.com | 6% |
| First_Last@iderapharma.com | 2% |
| F.Last@iderapharma.com | 2% |
| Last_First@iderapharma.com | 2% |
| FirLast@iderapharma.com | 1% |
| LastF@iderapharma.com | 1% |
| First_L@iderapharma.com | 1% |
| FirstMiddleLast@iderapharma.com | 1% |
| Last@iderapharma.com | 1% |
| FirstL@iderapharma.com | 1% |
| FLast@aceragen.com | 100% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com